Report of two children with subacute sclerosing panencephalitis displaying an atypical clinical course1 [4]

Journal of Emergency Medicine

Volumn 26, Issue 3, 2004, Pages 356-359

  Tepebaşili, Ibrahim ^a   Çaksen, Hüseyin ^a   Odabaş, Dursun ^a   Ataş, Bülent ^a   Akbayram, Sinan ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CARBAMAZEPINE; METHISOPRINOL; RIBAVIRIN;

ANAMNESIS; CASE REPORT; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CLINICAL FEATURE; DEATH; DISEASE COURSE; DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FEVER; FOLLOW UP; GAIT DISORDER; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; LABORATORY TEST; LETTER; MALE; NEUROLOGIC EXAMINATION; PATIENT MONITORING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPEECH DISORDER; SUBACUTE SCLEROSING PANENCEPHALITIS; VERBALIZATION;

ANTIVIRAL AGENTS; APHASIA; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; EMERGENCY MEDICINE; FATAL OUTCOME; FEMALE; GAIT ATAXIA; HUMANS; INOSINE PRANOBEX; INTERFERONS; MALE; RIBAVIRIN; SUBACUTE SCLEROSING PANENCEPHALITIS; TREATMENT OUTCOME;

EID: 17544394616     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2003.12.018     Document Type: Letter

References (26)

1. Çaksen H., Odabaş D., Ataş B. Seizures in a boy with subacute sclerosing panencephalitis during high-dose intrathecal interferon-alpha therapy. Pediatr Neurol. 27:2002;75.
2. Çaksen H., Odabaş D., Anlar Ö., Ataş B., Tuncer O. Onset of generalized seizures following intrathecal interferon therapy of SSPE. Pediatr Neurol. 29:2003;78-79.
3. Anlar B., Köse G., Gürer Y., Altunbaşak Ş., Haspolat S., Okan M. Changing epidemiological features of subacute sclerosing panencephalitis. Infection. 29:2001;192-195.
4. th edn:2000;946-951 WB Saunders, Philadelphia, PA.
5. nd edn:1998;MacKeith Press, London.
6. nd edn:1990;371-399 Raven Press, New York.
7. Jabbour J.T., Duenas D.A., Sever J.L., Krebs H.M., Horta-Barbosa L. Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry. JAMA. 220:1972;959-962.
8. Ciotti F., Casadei G., Biasini G., Papperini R., Guermani M. Long-term subacute sclerosing panencephalitis with sensorial transcortical aphasia. Description of a case. (in Italian) Pediatr Med Chir. 7:1985;463-465.
9. Sie T.H., Weber W., Freling G., Galama J., Spaans F., Vles J. Rapidly fatal subacute sclerosing panencephalitis in a 19-year-old man. Eur Neurol. 31:1991;94-99.
10. Silva C.A., Paula-Barbosa M.M., Pereira S., Cruz C. Two cases of rapidly progressive subacute sclerosing panencephalitis. Neuropathological findings. Arch Neurol. 38:1981;109-113.
11. Gökçil Z., Odabaşi Z., Aksu A., Vural O., Yardim M. Acute fulminant SSPE clinical and EEG features. Clin Electroencephalogr. 29:1998;43-48.
12. Rotteveel J.J., Renier W.O., Weemaes C.M., De Witte T.J. Plasmapheresis treatment in 2 children with SSPE (subacute sclerosing panencephalitis). Various considerations on symptomatology, pathophysiology and therapy. (in Dutch) Tijdschr Kindergeneeskd. 52:1984;59-63.
13. Yalaz K., Anlar B., Öktem F., et al. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology. 42:1992;488-491.
14. Anlar B., Gücüyener K., Imir T., Yalaz K., Renda Y. Cimetidine as an immunomodulator in subacute sclerosing panencephalitis a double blind, placebo-controlled study. Pediatr Infect Dis J. 12:1993;578-581.
15. Anlar B., Yalaz K., Imir T., Turanli G. The effect of inosiplex in subacute sclerosing panencephalitis a clinical and laboratory study. Eur Neurol. 34:1994;44-47.
16. Gürer Y.K., Kükner S., Sarica B. Intravenous gamma-globulin treatment in a patient with subacute sclerosing panencephalitis. Pediatr Neurol. 14:1996;72-74.
17. Anlar B., Yalaz K., Öktem F., Köse G. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology. 48:1997;526-528.
18. Anlar B., Yalaz K., Köse G., Saygi S. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis. J Child Neurol. 13:1998;557-559.
19. Haspolat Ş., Anlar B., Köse G., Coskun M., Yegin O. Interleukin-1beta, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols. J Child Neurol. 16:2001;417-420.
20. Tomoda A., Shiraishi S., Hosoya M., Hamada A., Miike T. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis. Pediatr Neurol. 24:2001;54-59.
21. Hosoya M., Shigeta S., Mori S., et al. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. Antimicrob Agents Chemother. 45:2001;943-945.
22. rd, North J.A., Murray B.K., Robins R.K. Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin. Antimicrob Agents Chemother. 26:1984;466-475.
23. Takahashi T., Hosoya M., Kimura K., et al. The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo. Antiviral Res. 37:1998;29-35.
24. Stephen B.T., Ramel A.C., Cormac A.O. Intraparenchymal alpha interferon and intraventricular ribavirin for subacute sclerosing panencephalitis (SSPE). Neurology. 54:2000;A430.
25. Ogle J.W., Toltzis P., Parker W.D., et al. Oral ribavirin therapy for subacute sclerosing panencephalitis. J Infect Dis. 159:1989;748-750.
26. Nihei K. Subacute sclerosing panencephalitis (SSPE). (in Japanese) Nippon Rinsho. 55:1997;908-915.